Literature DB >> 12189221

Heat shock protein inhibitor shows antitumor activity.

F B Dunn.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12189221     DOI： 10.1093/jnci/94.16.1194

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  2 in total

1.  Tamoxifen enhances the Hsp90 molecular chaperone ATPase activity.

Authors:  Rongmin Zhao; Elisa Leung; Stefan Grüner; Matthieu Schapira; Walid A Houry
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

2.  SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK.

Authors:  Yutaka Okawa; Teru Hideshima; Paul Steed; Sonia Vallet; Steven Hall; Ken Huang; John Rice; Amy Barabasz; Brianna Foley; Hiroshi Ikeda; Noopur Raje; Tanyel Kiziltepe; Hiroshi Yasui; Sotaro Enatsu; Kenneth C Anderson
Journal:  Blood       Date:  2008-10-23       Impact factor: 22.113
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.